Search - tctmd.com

Displaying 241 - 260 of 457

Sort: Relevancy | Date

News Features

Trial by Twitter: How a 280-Character Count Is Reshaping Cardiology

Michael O'Riordan

March 03, 2020

News Conference News CRT 2020

Positive Early Data for TAVR in Low-Risk Patients With Bicuspid Valves

Michael O'Riordan

February 27, 2020

News Industry News

New Data Confirms Cardiac Dimensions’ Carillon® System Shows Favorable Long-Term Survival Rate In Patients With Functional Mitral Regurgitation

February 25, 2020

News Daily News

Formal Shared Decision-Making Aid for TAVR Gets Mixed Reviews

Michael O'Riordan

January 31, 2020

News Daily News

Embolization Coils May Be an Option for Leaks After LAA Occlusion

Todd Neale

January 15, 2020

News Daily News

Diastolic BP, Heart Rate Strongly Linked to Death in Chronic Aortic Regurgitation

Todd Neale

January 08, 2020

News Daily News

Hybrid Approach to Reshaping Left Ventricle Offers Hope for HF Patients

L.A. McKeown

December 06, 2019

News Daily News

Long-term Watchman Data Reassure: CAP and CAP2 Registries

Michael O'Riordan

December 02, 2019

News Conference News PCR London Valves 2019

Durable 1-Year Results with TriClip Edge-to-Edge Repair for TR: TRILUMINATE

Michael O'Riordan

November 25, 2019

News Conference News PCR London Valves 2019

Solid 2-Year Outcomes for Portico, With Paravalvular Leak Rare

Michael O'Riordan

November 20, 2019

News Conference News AHA 2019

Full GALILEO Results Confirm Harm With Rivaroxaban After TAVR

Todd Neale

November 17, 2019

News Conference News AHA 2019

Early Surgery Beats a Conservative Approach in Asymptomatic AS: RECOVERY

Yael L. Maxwell

November 16, 2019

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for October 2019

Todd Neale

October 31, 2019

News Daily News

Gaps in Access to TAVR and SAVR: ‘Something Needs to Be Done’

L.A. McKeown

October 29, 2019

News Conference News TCT 2019

Watchman Adverse Events: Analysis Digs Into What’s Been Reported to the FDA

Todd Neale

October 04, 2019

News Conference News TCT 2019

TAVR Improves Health Status Over Surgery in Low-Risk Patients at 1 Year: PARTNER 3

Yael L. Maxwell

September 29, 2019

News Conference News TCT 2019

Oral Anticoagulation After TAVR Doesn’t Reduce Ischemic Cerebral Lesions: AUREA

Michael O'Riordan

September 28, 2019

News Conference News TCT 2019

Leaflet Thickening and Impaired Motion No Worse With TAVR: PARTNER 3 CT

Michael O'Riordan

September 27, 2019

Presentation TCT 2019

The Antiplatelet Drug Test to Determine Responsivity and the Next-Generation PFO Closure Migraine Trial

Presenter: Mark Reisman

September 27, 2019

$TCT 33: Bioprosthetic valve fracture performed pre versus post valve-in-valve transcatheter aortic valve replacement: Insights from bench testing$

Presentation TCT 2019

TCT 33: Bioprosthetic valve fracture performed pre versus post valve-in-valve transcatheter aortic valve replacement: Insights from bench testing

Presenter: Janarthanan Sathananthan, MD

September 25, 2019

Advertisement

Trial by Twitter: How a 280-Character Count Is Reshaping Cardiology

Positive Early Data for TAVR in Low-Risk Patients With Bicuspid Valves

New Data Confirms Cardiac Dimensions’ Carillon® System Shows Favorable Long-Term Survival Rate In Patients With Functional Mitral Regurgitation

Formal Shared Decision-Making Aid for TAVR Gets Mixed Reviews

Embolization Coils May Be an Option for Leaks After LAA Occlusion

Diastolic BP, Heart Rate Strongly Linked to Death in Chronic Aortic Regurgitation

Hybrid Approach to Reshaping Left Ventricle Offers Hope for HF Patients

Long-term Watchman Data Reassure: CAP and CAP2 Registries

Durable 1-Year Results with TriClip Edge-to-Edge Repair for TR: TRILUMINATE

Solid 2-Year Outcomes for Portico, With Paravalvular Leak Rare

Full GALILEO Results Confirm Harm With Rivaroxaban After TAVR

Early Surgery Beats a Conservative Approach in Asymptomatic AS: RECOVERY

TCTMD’s Top 10 Most Popular Stories for October 2019

Gaps in Access to TAVR and SAVR: ‘Something Needs to Be Done’

Watchman Adverse Events: Analysis Digs Into What’s Been Reported to the FDA

TAVR Improves Health Status Over Surgery in Low-Risk Patients at 1 Year: PARTNER 3

Oral Anticoagulation After TAVR Doesn’t Reduce Ischemic Cerebral Lesions: AUREA

Leaflet Thickening and Impaired Motion No Worse With TAVR: PARTNER 3 CT

The Antiplatelet Drug Test to Determine Responsivity and the Next-Generation PFO Closure Migraine Trial

TCT 33: Bioprosthetic valve fracture performed pre versus post valve-in-valve transcatheter aortic valve replacement: Insights from bench testing

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content